| Literature DB >> 28625589 |
Wan Aliaa Wan Sulaiman1, Liyana Najwa Inche Mat2, Hasnur Zaman Hashim3, Fan Kee Hoo2, Siew Mooi Ching4, Ramachandran Vasudevan5, Mohd Hazmi Mohamed6, Hamidon Basri3.
Abstract
Dengue is the most common arboviral disease affecting many countries worldwide. An RNA virus from the flaviviridae family, dengue has four antigenically distinct serotypes (DEN-1-DEN-4). Neurological involvement in dengue can be classified into dengue encephalopathy immune-mediated syndromes, encephalitis, neuromuscular or dengue muscle dysfunction and neuro-ophthalmic involvement. Acute disseminated encephalomyelitis (ADEM) is an immune mediated acute demyelinating disorder of the central nervous system following recent infection or vaccination. This monophasic illness is characterised by multifocal white matter involvement. Many dengue studies and case reports have linked ADEM with dengue virus infection but the association is still not clear. Therefore, this article is to review and discuss concerning ADEM in dengue as an immune-medicated neurological complication; and the management strategy required based on recent literature.Entities:
Keywords: Acute disseminated; Demyelinating diseases; Dengue virus; Encephalomyelitis; Nervous system disorders; Severe dengue
Mesh:
Year: 2017 PMID: 28625589 DOI: 10.1016/j.jocn.2017.05.033
Source DB: PubMed Journal: J Clin Neurosci ISSN: 0967-5868 Impact factor: 1.961